Uncategorized

According to a study published in the New England Journal of Medicine, Vemurafenib (Zelboraf) speeds the growth of squamous cell carcinoma. HealthDay explained that “roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas.”

A study published in The Lancet by Dr. Peter Gillgren indicates that a 2-cm excision margin is safe and as sufficient as 4-cm margins for the removal of melanomas that are at least 2-mm thick. This study took place in Sweden and involved a total of 936 patients. This study indicates what has been believed for over a decade, that large…

Galderma has launched  the Treatment Tracker, a free online program that allows patients to have a private, online diary that will keep a record of their: signs and symptoms treatment history photos upcoming Dermatologist appointments In addition, this program provides a list of potential psoriasis triggers, which can be customized to help patients manage their…

Skin cancer is the most common cancer in the United Stated. One should use a broad-spectrum sunscreen that protects against both UVA and UVB rays. The SPF rating system only applies to the protection the sunscreen has against UVB and will still be used. Here are the changes in labeling: The highest SPF rating will now…

Patients with advanced malignant melanoma taking the experimental drug, vemurafenib, were 63 percent less likely to dies than those who were given chemotherapy.  After three months, patients had a 74 percent reduction in the risk of skin cancer progression and half had tumor shrinkage compared to chemotherapy. This drug is designed to be used in patients…

Cleansing the body with bar soaps is still the most popular way to wash the body, but most bar soaps contain sodium lauryl sulfate that strips away natural oils from the skin. Some organic soaps, such as Burt’s Bees, and Dove do not. In the past decade, companies have created moisturizing soaps that moisturize and…